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Abstract: This article concerning the rate of accurate diagnosis of keratinocyte carcinoma is reported by experienced surgeons.
Keratinocyte carcinoma (KC) has been recently used in order to define basal cell carcinoma and squamous cell carcinoma. Although
an histopathologic analysis is standard for diagnosis, clinical diagnosis is still important for the choice of proper treatment.
In this prospective study, 204 lesions were excised following clinical pre-diagnosis of keratinocyte carcinoma. The lesions were
excised from the proper surgical limit for clinical diagnosis and sent for histopathologic examination. We have seen that we frequently
confuse BCC s and SCC s with actinic keratosis. According to these results, we found that our accurate diagnosis rate was 82% for
BCC and 78.8% for SCC. When compared with the results in the literature, our accurate diagnosis rate is high. We believe that the
gross examination of the lesion should be assessed with details such as age of the patient, sex, profession, and commencement and
development of the lesion, as these factors are very useful in achieving a high rate of accuracy in the definitive diagnosis.
We consider that accurate clinical pre-diagnosis is very important in the pigmented lesions, since the surgeon will define the excision
margin in accordance with this. In the case of wrong pre-diagnosis of benign tumor, the residue tumor risk will increase. These
lesions must be assessed by experienced doctors before excision.
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Introduction
Although the term non-melanoma skin cancer has
frequently been used for basal cell carcinoma (BCC) and
squamous cell carcinoma (SCC), there are other types of
nonmelanoma skin cancers, such as the adnexal tumors
and sarcomas whose cell types, behavior and
epidemiologic characteristics are different. Therefore, the
term keratinocyte carcinoma (KC) has recently been used
in order to define BCC and SCC (1). 90% of all skin
cancers include keratinocyte carcinoma. BCC and SCC
account for approximately 80% and 20% of keratinocyte
carcinoma respectively (1,2).
Since the mortality rate caused by keratinocyte
carcinoma is low, it is not considered significant (3).
However, deformities are caused by the excision of large
lesions, since 80% of them frequently occur on the face
and the morbidity rate increases. Thus, in order to

diagnose those lesions in the early period and prevent
residue tumor, the excision must be made with sufficient
surgical margin, and therefore the clinical diagnosis is
very important.
In our study, we have determined the accuracy of our
pre-diagnosis, the sex distribution, average age and
location in the patients on whom we operated with the
pre-diagnosis of keratinocyte carcinoma and who
attended our clinic during a 3 year period.
We compared our results with the publications in the
Index Medicus.

Material and Methods
This study includes the patients whom we operated on
under local anesthesia with the clinical diagnosis of
keratinocyte carcinoma. This prospective study comprises
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the period from January 2000 to December 2003. Any
lesion that had a prior biopsy was excluded. Each patient
was assessed by a senior author. When the diagnosis was
made, the questions of the age of the patient, sex,
location of the diagnosis and how long the lesion had
existed were investigated and the patients evaluated
according to the gross examination results of the lesion.
A clinical diagnosis in this context was then made. The
lesions were excised within the proper surgical limit
according to the clinical diagnosis and sent for
histopathologic examination (Table 1).

evaluated and reasons why they were confused with such
tumors were discussed. In addition, the sex and age
distributions of the lesions were determined in
accordance with this histopathological diagnosis, and the
topographical distribution was defined.

Histopathological diagnosis was compared with the
clinical diagnosis and the accurate diagnosis rates were
found. The lesions which were incorrectly diagnosed were

The lesions were grouped as benign, pre-malignant
and malignant in accordance with the histopathological
diagnosis and they were compared with the clinical
diagnosis. The accurate and wrong diagnosis rates were
determined (Table 2,3). Then, the age and sex
distributions of keratinocyte carcinoma diagnoses were
defined (Figure 1,2). Finally, the tables showing the
locations of keratinocyte carcinomas were established
(Table 4).

Table1. Patient distribution.

Table 3. Histopathological versus clinical diagnosis in SCC.

Lesions number

Patient number

1
2
3
10
13

170
4
1
1
1

Total: 204

177

Clinical pre-diagnosis

Table 2. Histopathological versus clinical diagnosis in BCC.
Clinical diagnosis
BCC
Histopathological diagnosis
Benign
Nevus
Ulcer
Dermatofibroma
Chondrosyringoma
Seborrheic keratosis
Pilosebaseous unit
Inflamation
Molluscum contagiosum
Keratoacanthoma
Premalignant
Aktinic keratosis
Carcinoma insitu
Malignant
BCC
SCC
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Lesion number

SCC
Histopathological diagnosis
Benign
Pilar tumor
Epithelial Hyperplasia
Premalignant
Aktinic Keratosis
Malignant
SCC
BCC
MM

%

33

1
2

3.03
6

3

9.09

26
1

78.8
3.03

%
Table 4. Topographic distribution of the keratinocyte carcinoma.

171

1
2
1
1
3
1
2
1
1

0.38
1.16
0.38
0.38
1.75
0.38
1.16
0.38
0.38

10
1

5.84
0.38

141
6

Lesions number

82.4
3.5

Location

BCC

Scalp
Frontal zone
Temporal zone
Periorbital zone
Nasal zone
Periauriculer zone
Buccal zone
Perioral zone
Mentum
Neck
Upper arm
Trunk
Lower arm

18
10
7
15
52
8
13
4
1
1
10
1
1

TOTAL

141(%81.5)

SCC

1
4
1
1
15
6
1
1
2
32(%18.5)
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30
25

Male

20

Female

15
10
5
0

0-20 20-30 30-40 40-50 50-60 60-70 70-80 80-90 90Figure 1. BCC; Age-Sex distribution graphics.

Results
Clinic and Histopathological Diagnosis
During the 3 years, 204 lesions were excised from
177 patients in accordance with the above-mentioned
protocol (Table 1). 171 lesions were operated on with a
BCC clinical diagnosis and 33 lesions were operated on
with a SCC clinical diagnosis. When the results were
assessed after the histopathological diagnosis, 6 of the
lesions which were excised with BCC pre-diagnosis were
diagnosed as SCC (Table 2). It was observed that 26 of
the lesions excised with the SCC clinical diagnosis were
diagnosed histopathologically as SCC (Table 3).
According to these results, we established that our
accurate diagnosis rate was 82% for BCC and 78.8% for
SCC.
It was observed that BCC is mostly confused with
actinic keratosis clinically at the rate of 5.84% and this is
followed by the wrong clinical diagnosis of SCC at the
rate of 3.5%. Histopathologically, in the patients with
SCC diagnosis, the wrong clinical diagnosis of BCC does
not occur but SCC is mostly confused with actinic
keratosis at the rate of 9%.
In accordance with the obtained histopathological
diagnosis, we observed that 81.4% of the patients with
keratinocyte carcinoma were BCC and 18.6% were SCC.

Topographic Distribution of the Lesions
When the anatomic distribution of these lesions was
examined in accordance with the histopathological
diagnosis, it was observed that 95.6% of the
keratinocyte carcinoma were localized in the head-neck
region. The head-neck region was separated into 10
zones in accordance with these locations. Topographic
distribution was made by considering those zones (Table

9
8
7
6
5
4
3
2
1
0

Male
Female

0-20 20-30 30-40 40-50 50-60 60-70 70-80 80-90 90Figure 2. SCC; Age-Sex distribution graphics.

4). It was observed that BCC was most frequently
located in the nasal zone and this was followed by the
scalp zone.
When the topographic distribution of SCC was
examined, it was observed that the perioral zone was the
most frequently affected zone, especially the lower lip at
the rate of 46% and this was followed by the nasal zone
(Table 4).
Age and Sex
51% of 141 patients with BCC diagnosis were men
and 49% were women (Figure 1). 74% of 32 patients
with SCC diagnosis were men and 26% were women
(Figure 2).
When the age distribution was examined, it was
observed that BCC mostly peaked between the ages of 60
and 70 and it occurred more among the 50 and 80 years
than others (Figure 1).
It was also observed that SCC peaked among the 6070 age range and in men. As the SCC was clearly
observed in the 40-70 age range in men, the incidence in
the 70-80 age range of both sexes became equal (Figure
2).

Discussion
The main objective of this study is to determine the
accuracy rate of a clinical diagnosis made by a senior
author. Even if the histopathological examination
becomes the reference for the definite diagnosis, the
clinical diagnosis is important for planning suitable
treatment. The surgical excision in keratinocyte
carcinoma is made for both diagnosis and treatment
purposes in the patient group included in the study. Since
the excision limit is determined in accordance with this
247
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pre-diagnosis, the clinical diagnosis has great importance
for avoiding residue lesion.
The clinical diagnosis of keratinocyte carcinomas may
sometimes be difficult. The principle indicators for
diagnosis are the morphology, color and structure of the
skin. Information such as the profession of the patient,
the region that he/she lives and the periods of the lesion’s
existence obtained from the patient’s history are useful
for definitive diagnosis.
BCC grows slowly, and in general, it causes an ulcer,
being asymptomatic until it bleeds. It occurs frequently on
the zones which are subjected to direct sunshine such as
the face and extremities. While the lesions have round,
oval, papule or nodule shapes in the early periods, central
ulceration frequently occurs in the late period. Its color
may be bright, translucent or matt from pink to red. It is
hard at palpation. Due to the typical appearance of BCC,
its clinical diagnosis is easy (1-4). Telangiectasis, atrophy,
drying or irregular pigmentation may occur on the
surrounding tissue. It may be confused with actinic
keratosis because of these characteristics. Some BCCs
may be pigmented or nodular. They are frequently
confused with malignant melanomas. Sometimes, BCC
may be observed as an irregular, thin, fluffy atrophic
plate. Bowen’s disease (observed as a red drying plate)
should be considered in the definitive diagnosis. Ulcerated
BCCs may also be confused with SCCs (4, 5).
SCC are frequently observed on the zones which are
subjected to direct sunshine such as face, ear, back of
the hand. The wrinkling, drying, telangiectasis and
irregular pigmentation may be observed on the
neighboring skin as in actinic keratosis. The developing
risk of SCC increases on the basis of sinus tract, radio
dermatitis zone, burn scar, and venous damage which
become chronic and ulcerated. SCC usually develops more
rapidly than BCC. It is typically erythematous, indurated,
papular, plate or nodule types (1, 2, 6).
When we examined the BCC clinical pre-diagnosis
defined by considering those criteria (Table 2), we have
seen that we frequently confuse BCCs with actinic keratosis
at the rate of 5.8%, and this is followed by wrong prediagnosis of SCC at the rate of 3.5%. Our accurate
diagnosis rate in BCC has been found to be 82.3%.
When the SCC clinical pre-diagnoses were examined
(Table 3), we observed that we frequently faultily
diagnose actinic keratosis at the rate at 9.09% and this is
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followed by the wrong diagnosis of epithelial hyperplasia
with 6%. Our accurate diagnosis rate in SCC has been
found to be 78.8%.
The obtained results have been compared with other
studies in the literature.
Bolognia et al. stated in 1990 that their accurate
diagnosis rate in BCC was 43% and in SCC 14% (7).
Hallock et al. also reported in 1998 that the accurate
diagnosis rate in BCC was 54% and in SCC 25% in their
study over 5 years. They have stated that they frequently
confused SCC with Bowen’s disease and actinic keratosis
at a rate of 41% and this was followed by wrong prediagnosis of BCC at the rate of 23%. The reasons they
gave for these wrong diagnosis rates were that they had
not been educated sufficiently on the clinical pathology
during their internship period and there were no similar
terms for these tumors as described in their text books.
They also pointed out that BCC, which spreads on the
surface, was confused with Bowen’s disease in the
definitive diagnosis (2).
Har-Shai et al., stated in their study in 2001 that their
accurate diagnosis rate of BCC was 66.8% and of SCC
41.7% (8). In the study of Har-Shai et al., the wrong
clinical, diagnosis in BCC has been frequently made as
actinic keratosis (7.5%) as in our study. This has been
followed by Bowen’s disease with 6.1% and SCC with
5.7%. The accurate diagnosis rate in SCC was 41.7%.
They have also confused it with BCC in 43%, followed by
actinic keratosis in 11.1% of cases.
When compared with the other results in the
literature, we found that our accurate diagnosis rate of
82% for BCC and 78% for SCC is high. We believe that
the gross examination of the lesion should be assessed
with the details such as the age of the patient, sex,
profession, commencement and development of the
lesion as they are very useful in the definitive diagnosis
for obtaining these high rates.
80% of keratinocyte carcinomas include BCC and
20% include SCC. In accordance with the pathologic
diagnosis, 81.4% of keratinocyte carcinomas were BCC
and 18.6% were SCC in our study. The BCC / SCC rate is
supported by other studies in the literature as 3/1 and
4/1 (1-5). Ceylan et al. have reported the appearance rate
of BCC as 73.4% and of SCC as 26.6% in their study (9).
In Australia, Stapler et al. have given the rate of BCC/SCC
as 4/1 in 1985 and as 2.5/1 in 1995 (10).
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Many host and environmental factors contribute to
the risk of developing KC. Skin colour is a major risk
factor for KC. One of the important factors in the
development of keratinocyte carcinoma is exposure to
ultraviolet light. The relationship between being exposed
to direct sunlight and development of skin cancer has
been known since 1894 when Paul-Gerson Unmam
defined the pre-cancerous histological changes on the
skins of sailors (11). While being exposed to ultraviolet
light cumulatively during the lifetime is a risk factor for
SCC, exposure to ultraviolet light intermittently for a long
time is important for malignant melanoma. However its
accuracy is not proved. Even if it is known that the
sunlight plays a role in the development of BCC, the
pattern importance of exposure is not indicated (12,13).
It is observed that the incidence of KC changes due to
the geographic region (3,9,14,15).
When we look at the frequency of occurrence of skin
cancer in Turkey and the statistics of the Data Processing
Department of the Ministry of Health, it is seen that it is
usually not placed into subdivisions, but is termed skin
cancer. In accordance with the data, it is observed that
skin cancer incidence is in the 5th rank, with
211/100000 in men and 4th rank with 210/100000 in
women. In a study which was executed in Australia, it was
stated that KC was the most frequently observed cancer
and its incidence for BCC was 788/100.000 and for SCC,
166/100.000 (10). In the study which was executed in
the Netherlands (16), keratinocyte carcinoma incidence
increased in men from 42/100.000 to 52/100.000
between 1975 and 1985 and in women from
24/100.000 to 38/100.000. In a publication which was
issued in Finland (17), the SCC incidence in men was
reported as 9/100.000 and in women as 87/100.000. In
the U.S.A., the incidence (17) for BCC was 41/100.000
and for SCC was 41.1/100.000.
When all these incidences are examined together, the
keratinocyte carcinoma incidence is significantly lower in
the Northern European countries such as England,
Finland and Netherlands, than Turkey (10,16,17).
Considering the geographic settlement, it is known that
Turkey has more sunlight than those countries.
The keratinocyte carcinoma is localized on the head,
neck and hand zones which are frequently exposed to
sunlight. The possibility of occurrence is high in men who
are exposed to sunlight for a long time such as farmers

and sailors, and increases in parallel to age. It was
reported that it occurred at the rate of 20% on the zones
which are not exposed to sunlight (1-3).
In a study which was published in Pennsylvania, 56%
of BCC and 60% of SCC are localized on the head-neck
zone. In another study which was executed in Finland
(16), it was reported that 77% of BCC and 75% of SCC
were localized on the head-neck zone. Ceylan et al. from
‹zmir (9) have indicated that 96.9% of BCC and 94.8%
of SCC were located in the head-neck zone. In the
publications from Australia (10), it is stated that the
keratinocyte carcinoma is the most common tumor and is
observed at the rate of 96% in the head-neck zone. We
also examined the topographic distribution of the lesions
in our study. It was found that 97.8% of BCC and 87.5%
of SCC are localized on the head-neck zone.
When we examine the age-sex distribution of KC, the
significant increase in BCC occurred in both men and
women between 60 and 70 years in our series. In SCC,
while there is a significant increase in men between 60
and 70 years, it is more frequently observed in women
between 70 and 80 years. In accordance with our study,
when the BCC was observed in 51% of men and 49% of
women, the SCC was observed in 74% of men and 26%
of women. While it is observed that BCC occurred equally
in both men and women, SCC was significantly higher in
men.
Her-Shai et al. (3) have stated in their study that the
occurrence ratio of male to female was 3/2 in BCC and
3/2 in SCC. Ceylan et al. (9) have reported in their study
that the Male/Female ratio for SCC was 2.86 and that
SCC was observed in men more frequently than women
while BCC occurred equally in both men and women.
When these studies are assessed generally, it is
observed that the unity of advanced age and male sex is
a risk for developing both BCC and SCC. It is observed
that the BCC incidence is higher in men after 60 years
old.

Conclusion
We consider that accurate clinical pre-diagnosis is very
important in pigmented lesions. The surgeon will define
the excision margin in accordance with this pre-diagnosis.
In case of wrong pre-diagnosis of a benign tumor, the
residue tumor risk will increase. Conversely, when the
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benign tumor is defined as malignant, the excision will be
made unnecessarily and this may cause distortion in the
aesthetic units.

important. They must be assessed together with the
macroscopic examination of the lesion.

Because of the reasons mentioned above, we believe
that an accurate clinical diagnosis of keratinocyte
carcinomas is very important and that such lesions must
be assessed by experienced doctors before the excision.
When the accurate clinical diagnosis is made, details such
as age, sex, settlement region and geographic region
which we mentioned statistically also become very
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